Nan-Shih Liao is an expert in Immunology at Academia Sinica (Taiwan). Nan-Shih Liao has authored 54 publications, the most recent in 2025. SLR score: 212 (community average: 125). How the SLR is computed.

LeadR Profile

Nan-Shih Liao, PhD Academia Sinica Taiwan
212 ScienceLeadR Reputation 212
Network Map

Immunology

Subspecialties:

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1987 - 2026

Source: PubMed

Institute of Molecular Biology, Academia Sinica

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 54

Citations

Citations: 2 564 1st author: 6 Last author: 23 Unique author: 1


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
cGAS and STING in Host Myeloid Cells Are Essential for Effective Cyclophosphamide Treatment of Advanced Breast Cancer.
PMID 40227734 — cells, breast neoplasms, cyclophosphamide, neoplasms, myeloid cells, breast, therapeutics, chromosomal instability
Cancers (Basel)20250
Syngeneic natural killer cell therapy activates dendritic and T cells in metastatic lungs and effectively treats low-burden metastases.
PMID 39835538 — cells, lung, biological science disciplines, killer cells, natural, neoplasms, neoplasm metastasis, therapeutics, dendritic cells
Elife20250
Long-term hematopoietic transfer of the anti-cancer and lifespan-extending capabilities of a genetically engineered blood system by transplantation of bone marrow mononuclear cells.
PMID 38752723 — cells, genes, bone marrow, blood, biological science disciplines, regenerative medicine, aging, neoplasms, bone marrow transplantation, stem cells, leukocytes, transplantation
Elife20241
Syngeneic natural killer cell therapy activates dendritic and T cells in metastatic lungs and effectively treat low-burden metastases
OpenAlex W4396685403 — cells, lung, killer cells, natural, neoplasms, neoplasm metastasis, therapeutics
bioRxiv (Cold Spring Harbor Laboratory)20240
Inactivation of mitochondrial pyruvate carrier promotes NLRP3 inflammasome activation and gout development via metabolic reprogramming.
PMID 36708143 — risk, gout, allergy and immunology, macrophages, inflammasomes
Immunology202311

LeadR Networks

Main global connection map